Rita
More to the point, what do the results show? Are Australians VitD deficient as well as little Englanders?
If not, why is it being measured so much? If they are, have we got the reference range wrong?
Michael
From: Clinical biochemistry discussion list [mailto:[log in to unmask]]
On Behalf Of Rita Horvath
Sent: 09 October 2013 00:52
To: [log in to unmask]
Subject: Re: vitamin D measurements
Very similar data here in sunny (but very “sunscreened”) Australia too, with (on average) every 7th Australian having had a vit D
test in 2012. On average this meant 5.5 AUD spent on vit D testing for every single citizen in Australia in 2012. However, the government is reviewing the reimbursement schedule and the below data come from their review protocol.
(NB: France and the UK have about 3x as much population as Australia, so the figure from France indicates that the situation is still somewhat
better in France than in AU – mind you the French may not use as much sunscreen as the Aussies; and the Brits perhaps still do not get enough sunshine, in spite of the global warming trends and increasing hot summers in the UK?
J Time for action indeed!
Table A.2: Number of claims for Vitamin D testing MBS items since 2000/2001
MBS item no |
Financial year |
|||||||||
02/03 |
03/04 |
04/05 |
05/06 |
06/07 |
07/08 |
08/09 |
09/10 |
10/11 |
11/12 |
|
66608 |
73,330 |
117,474 |
171,288 |
249,933 |
445,854 |
847,029 |
1,492,904 |
2,219,553 |
2,982,658 |
3,481,966 |
66609 |
|
|
|
|
743 |
13,329 |
9,442 |
11,397 |
15,414 |
7,203 |
Total |
73,330 |
117,474 |
171,288 |
249,933 |
446,597 |
860,358 |
1,502,346 |
2,230,950 |
2,998,072 |
3,489,169 |
Source: Department of Human Services Medicare
the number of claims for vitamin D testing is particularly significant for females aged between 24 and 84, showing a marked increase from 2008 to 2012
(green line)
compared to 2004-2008 (red line)
and 2000 to 2004 (blue line).
Figure A.1: Usage of MBS item 66608 by age and gender since 2000
Figure A.2 shows that the annual MBS benefits paid for vitamin D testing (item numbers 66608 and 66609) has increased significantly from $2.6 million in 2002 to $126.5 million
in 2012. The significant increase in the benefits paid for both item numbers is consistent with the increase in the volume of claims.
Figure A.2: Benefits paid for MBS item number 66608 and 66609 since 2002/2003
Source: Department of Human Services Medicare
Kind regards, Rita
Prof. Andrea Rita Horvath, MD, PhD, EurClinChem, FRCPath, FRCPA
Past President of the European Federation of Clinical Chemistry and Laboratory Medicine
Clinical Director,
SEALS North, Department of Clinical Chemistry
Level 4, Campus Centre, Prince of Wales Hospital
Barker Street, Randwick, NSW 2031, Sydney, Australia
Tel: (+612)-9382 9078
Fax: (+612)-9382 9099
Mobile No: (+61)-404 027 843
From: Clinical biochemistry discussion list [mailto:[log in to unmask]]
On Behalf Of Joseph WATINE
Sent: Sunday, 6 October 2013 8:05 PM
To: [log in to unmask]
Subject: vitamin D measurements
In France vitamine D measurement in blood is now the 5th lab test in terms of costs for the "sécurité sociale": it costed almost 100.000.000 Euros in 2111, and the number of requests of vitamin D are increasing exponentially:
the costs were below 40.000 Euros in 2009. At such a speed of increase, it would not be surprising that the costs would reach 150.000.000 Euros in 2013 and thus vitamin D would become the 2nd most costly test for the collectivity in France just after blood
cell counts which cost 300.000.000 Euros each year (quite stable).
I would be interested to know whether or not such a waste of collective ressources are specific to France or if the same happens elsewhere in the world, particularly in the UK.
Best regards, Joseph, Villefranche-de-Rouergue, France
Dr Joseph Watine, PH, AIHP, PharmD, AAHU, EurClinChem
Laboratoire de Biologie Polyvalente
Centre Hospitalier La Chartreuse
Avenue Caylet
12200 Villefranche-de-Rouergue
France
La información contenida en el presente e-mail es confidencial y está reservada para el uso exclusivo de su destinatario. Se prohíbe estrictamente
la distribución, copia o utilización de esta información sin el previo permiso de su destinatario. Si usted no fuera el destinatario, por favor notifíquelo inmediatamente al remitente y elimine el presente mensaje de su sistema informático.
Information contained in this e-mail is confidential and is intended for the use of the addressee only. Any dissemination, distribution, copying or use of this communication without prior permission of the addressee is strictly
prohibited. If you are not the intended addressee, please notify the sender immediately by reply and then delete this message from your computer system.
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the
internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site
http://www.acb.org.uk Green Laboratories Work
http://www.laboratorymedicine.nhs.uk List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
---------------------------------------------------------------------------------------------
Illawarra Shoalhaven Local Health District, South East Sydney Local Health District and Sydney Children's Hospital Network (Randwick Campus) Confidentiality Notice
This email, and the files transmitted with it, are confidential and intended solely for the use of the individual or entity to whom they are addressed. If you are not the intended recipient, you are not permitted to distribute or use this email or any of its attachments in any way. We also request that you advise the sender of the incorrect addressing.
This email message has been virus-scanned. Although no computer viruses were detected, Illawarra Shoalhaven Local Health District, South East Sydney Local Health District and Sydney Children's Hospital Network (Randwick Campus) accept no liability for any consequential damage resulting from email containing any computer viruses.
We care for our environment. Please only print this e-mail if necessary.
|
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views
expressed are those of the individual and they are responsible for all message content. ACB Web Site
http://www.acb.org.uk Green Laboratories Work
http://www.laboratorymedicine.nhs.uk List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/